Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study (Q33385242)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study |
scientific article |
Statements
1 reference
Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study (English)
1 reference
Keiichi Fujiwara
1 reference
Junzo Kigawa
1 reference
Shoji Nagao
1 reference
Jun Noma
1 reference
Nobuo Akamatsu
1 reference
Yasunari Miyagi
1 reference
Fumitaka Numa
1 reference
Makoto Okada
1 reference
Eriko Aotani
1 reference
1 July 2009
1 reference
1 reference
19
1 reference
834-837
1 reference
Identifiers
1 reference
1 reference